1 Background
Histopathological response to neoadjuvant-chemotherapy(NACT) measured as
tumor necrosis(TN) has been reported to be prognostic of outcomes post
HDMTX- based chemotherapy. We studied outcomes based on different
cut-offs of TN and delineated clinical-laboratory parameters predictive
of TN on a non-HDMTX chemotherapy backbone.